Frank Lis

Mr. Lis serves as the President, the Chief Executive Officer, and a member of the Board of Managers of Kineticos Ventures and, along with Mr. Maingi, controls the General Partner. In addition to serving on the Investment Committee, Mr. Lis expects to be active in sourcing new investment opportunities and overseeing active portfolio companies for the Fund. Mr. Lis has over 30 years of experience as a senior executive in the pharmaceutical and biotechnology areas and has an extensive background in drug development, manufacturing, supply chain, quality systems, and commercial operations.

Prior to joining Kineticos Ventures, Mr. Lis served as a senior executive at leading pharmaceutical services firms. Mr. Lis also serves as a board member and advisor to a number of start-up biotechnology companies. Most recently, Mr. Lis was President of Sharp Clinical Services with responsibility for the global drug development business unit of UDG Healthcare plc. Prior to that, Mr. Lis was Vice President and General Manager at Catalent Pharma Solutions, responsible for managing the clinical supply services business with sites in the United States, the United Kingdom, and Germany. In addition to his operational responsibilities, Mr. Lis has led the diligence, investment, and integration of numerous acquisitions during his career.

Mr. Lis earned a Bachelor of Science in General Science from Villanova University.